Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-14
DOI
10.1186/s12935-021-02390-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MYC as a Target for Cancer Treatment
- (2021) Michael J Duffy et al. CANCER TREATMENT REVIEWS
- Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
- (2021) Sarah K. Madden et al. Molecular Cancer
- EIF4A3: a gatekeeper of autophagy
- (2021) Despoina Sakellariou et al. Autophagy
- Early detection of pancreatic cancer
- (2020) Stephen P Pereira et al. Lancet Gastroenterology & Hepatology
- Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.
- (2020) Andrew Eugene Hendifar et al. JOURNAL OF CLINICAL ONCOLOGY
- Drugging “undruggable” genes for cancer treatment: Are we making progress?
- (2020) Michael J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- A First-in-Human Phase I Study to Evaluate the ERK1/2 Inhibitor GDC-0994 in Patients with Advanced Solid Tumors
- (2019) Andrea Varga et al. CLINICAL CANCER RESEARCH
- Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway
- (2019) Xiju Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas
- (2019) Long-Sheng Chang et al. MOLECULAR CANCER THERAPEUTICS
- Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy
- (2018) Chao Yao et al. Autophagy
- Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer
- (2018) Eric Van Cutsem et al. INTERNATIONAL JOURNAL OF CANCER
- Highly stable and efficient all-inorganic lead-free perovskite solar cells with native-oxide passivation
- (2018) Min Chen et al. Nature Communications
- Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours
- (2017) H Yurugi et al. ONCOGENE
- Yeast eIF4A enhances recruitment of mRNAs regardless of their structural complexity
- (2017) Paul Yourik et al. eLife
- Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor
- (2016) Shintaro Iwasaki et al. NATURE
- Inhibition of the CRAF/prohibitin interaction reverses CRAF-dependent resistance to vemurafenib
- (2016) N A Doudican et al. ONCOGENE
- Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
- (2015) F. Raza et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MicroRNAs as regulators and mediators of c-MYC function
- (2015) Rene Jackstadt et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer
- (2015) A. Wiegering et al. Cancer Discovery
- Targeting MYC Translation in Colorectal Cancer
- (2015) A. Castell et al. Cancer Discovery
- A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors
- (2014) P. L. Bedard et al. CLINICAL CANCER RESEARCH
- Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
- (2014) Dimitris Stellas et al. JNCI-Journal of the National Cancer Institute
- Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma
- (2014) Zhou Luan et al. Molecular Cancer
- Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation
- (2014) ZHOU LUAN et al. Molecular Medicine Reports
- eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
- (2014) Lise Boussemart et al. NATURE
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- Direct reprogramming by oncogenic Ras and Myc
- (2013) I. Ischenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMT and Dissemination Precede Pancreatic Tumor Formation
- (2012) Andrew D. Rhim et al. CELL
- Endogenous Myc maintains the tumor microenvironment
- (2011) N. M. Sodir et al. GENES & DEVELOPMENT
- Myc-modulated miR-9 makes more metastases
- (2010) Yeesim Khew-Goodall et al. NATURE CELL BIOLOGY
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
- (2010) Li Ma et al. NATURE CELL BIOLOGY
- Canonical Initiation Factor Requirements of the Myc Family of Internal Ribosome Entry Segments
- (2009) K. A. Spriggs et al. MOLECULAR AND CELLULAR BIOLOGY
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
- (2008) C.-J. Lin et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started